Abstract: A light-emitting device is provided. comprises: a light-emitting stack comprising an active layer emitting a first light having a first peak wavelength ? nm; and an adjusting element stacked on and electrically connected to the active layer, wherein the adjusting element comprises a diode emitting a second light having a second peak wavelength between 800 nm and 1900 nm; wherein a forward voltage of the light-emitting device is between (1240/0.8?) volt and (1240/0.5?) volt, and a ratio of the intensity of the first light emitted from the active layer at the first peak wavelength to the intensity of the second light emitted from the diode at the second peak wavelength is greater than 10 and not greater than 1000.

Abstract: The present disclosure is related to an optoelectronic device comprising a semiconductor stack comprising a first surface and a second surface opposite to the first surface; a first contact layer on the first surface; and a second contact layer on the second surface, wherein the second contact layer is not overlapped with the first contact layer in a vertical direction; wherein the second contact layer comprises a plurality of dots separating to each other and formed of semiconductor material.

Abstract: A light-emitting device is provided. The light-emitting device comprises: a light-emitting stack having an active layer emitting first light having a peak wavelength ? nm; and an adjusting element stacked electrically connected to the active layer in series for tuning a forward voltage of the light-emitting device; wherein the forward voltage of the light-emitting device is between (1240/0.8?) volt and (1240/0.5?) volt.

Abstract: A light-emitting device is provided. The light-emitting device comprises: a light-emitting stack having an active layer emitting first light having a peak wavelength ? nm; and an adjusting element stacked electrically connected to the active layer in series for tuning a forward voltage of the light-emitting device; wherein the forward voltage of the light-emitting device is between (1240/0.8?) volt and (1240/0.5?) volt.

Abstract: An extract of Cynanchum sp. in use of arthritis treatment is provided. The extract of Cynanchum sp. and an active ingredient contained therein, antofine, are applicable to a method, pharmaceutical composition and dietary supplement for treatment of arthritis. A mass production of antofine from plant extracts is also provided.

Abstract: A controlled device includes a non-volatile memory, a power pin, and a controller. The controller is configured for performing, through a negotiation module, a power negotiation operation with a controlling device via the power pin; receiving a programming declaration from the controlling device via the power pin; disabling the negotiation module according to the programming declaration; receiving a programming data from the controlling device via the power pin after the negotiation module is disabled; and writing the programming data into the non-volatile memory. In other embodiment, the controlled device can further includes at least one configuration channel pin for receiving the programming declaration therethrough.

Abstract: A pharmaceutical composition for alleviating or treating gout and the applications thereof are provided. The pharmaceutical composition includes p-coumaryl diacetate as an active ingredient.

Abstract: An extract of Cynanchum sp. in use of arthritis treatment is provided. The extract of Cynanchum sp. and an active ingredient contained therein, antofine, are applicable to a method, pharmaceutical composition and dietary supplement for treatment of arthritis. A mass production of antofine from plant extracts is also provided.

Abstract: A pharmaceutical composition with an immunomodulating function is provided, including an extract of Bupleurum obtained by grinding the Bupleurum, adding the ground Bupleurum to a solvent and isolating the extract from the solvent, wherein the Bupleurum comprises Bupleurum krlovianum, Bupleurum longiradiatum, Bupleurum smithii, Bupleurum pusillum, Bupleurum longicaule, Bupleurum salicifolium, Bupleurum scorzonerifolium and Bupleurums with at least one of the nucleotide sequences selected from a group consisting of SEQ ID NOs. 1˜6 and a nucleotide sequence with no more than 1% of the nucleotide sequence divergences of SEQ ID NOs. 1˜6, or combinations thereof.

Abstract: A dimming apparatus transmitting control signals with AC power line (10) is applied to an alternating current power source (20), a light emitting diode driving power unit (40), and a light emitting diode unit (30). The dimming apparatus transmitting control signals with AC power line (10) includes an input voltage detection unit (102), a one-shot signal unit (104), an AND gate unit (106), a pulse width modulation dimming signal unit (108), an inductor unit (110), a first switch unit (114), a dimming signal recovery unit (124), and a second switch unit (122). The input voltage detection unit (102) is electrically connected to the alternating current power source (20), the inductor unit (110), and the one-shot signal unit (104). The AND gate unit (106) is electrically connected to the one-shot signal unit (104), the pulse width modulation dimming signal unit (108), and the first switch unit (114).

Abstract: A dimming apparatus transmitting control signals with AC power line (10) is applied to an alternating current power source (20), a light emitting diode driving power unit (40), and a light emitting diode unit (30). The dimming apparatus transmitting control signals with AC power line (10) includes an input voltage detection unit (102), a one-shot signal unit (104), an AND gate unit (106), a pulse width modulation dimming signal unit (108), an inductor unit (110), a first switch unit (114), a dimming signal recovery unit (124), and a second switch unit (122). The input voltage detection unit (102) is electrically connected to the alternating current power source (20), the inductor unit (110), and the one-shot signal unit (104). The AND gate unit (106) is electrically connected to the one-shot signal unit (104), the pulse width modulation dimming signal unit (108), and the first switch unit (114).

Abstract: A pharmaceutical composition with an immunomodulating function is provided, including an extract of Bupleurum obtained by grinding the Bupleurum, adding the ground Bupleurum to a solvent and isolating the extract from the solvent, wherein the Bupleurum comprises Bupleurum krlovianum, Bupleurum longiradiatum, Bupleurum smithii, Bupleurum pusillum, Bupleurum longicaule, Bupleurum salicifolium, Bupleurum scorzonerifolium and Bupleurums with at least one of the nucleotide sequences selected from a group consisting of SEQ ID NOs. 1˜6 and a nucleotide sequence with no more than 1% of the nucleotide sequence divergences of SEQ ID NOs. 1˜6, or combinations thereof.

Abstract: A method of forming an ultraviolet curable paint coating is provided. First, an ultraviolet curable paint composition is formed by mixing, based on 100 parts by weight of the ultraviolet curable paint composition, 1 to 10 parts by weight of a photo-initiator, 5 to 20 parts by weight of an organosilane compound, 5 to 30 parts by weight of a binding agent, 0.1 to 15 parts by weight of a catalyst, and an ultraviolet curable resin, wherein a number of the functional group of the binding agent is more than that of the organosilane compound. Thereafter, a sub coating is formed by using the ultraviolet curable paint composition, and an ultraviolet curable paint coating is then formed by contacting the sub coating with a paint, wherein the unreacted hydroxyls of the sub coating react with the paint to facilitate the paint to adhere to a surface of the sub coating.